Fernandez, Conrad V <br/><br/>
Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  01 2018 
 - 254-261 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2017.73.7999  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Biomarkers, Tumor--genetics<br/>Chemoradiotherapy, Adjuvant--adverse effects<br/>Child<br/>Child, Preschool<br/>Chromosomes, Human, Pair 1<br/>Chromosomes, Human, Pair 16<br/>Dactinomycin--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Genetic Predisposition to Disease<br/>Humans<br/>Infant<br/>Kidney Neoplasms--genetics<br/>Loss of Heterozygosity<br/>Lymph Nodes--pathology<br/>Lymphatic Metastasis<br/>Male<br/>Neoplasm Staging<br/>Nephrectomy<br/>Phenotype<br/>Progression-Free Survival<br/>Prospective Studies<br/>Radiation Dosage<br/>Risk Factors<br/>Time Factors<br/>Vincristine--administration & dosage<br/>Wilms Tumor--genetics